咨询与建议

看过本文的还看了

相关文献

该作者的其他文献

文献详情 >Umbilical cord:an unlimited so... 收藏

Umbilical cord:an unlimited source of cells differentiable towards dopaminergic neurons

Umbilical cord:an unlimited source of cells differentiable towards dopaminergic neurons

作     者:Mahdi Eskandarian Boroujeni Mossa Gardaneh 

作者机构:Department of Stem Cells and Regenerative Medicine Faculty of Medical Biotechnology National Institute of Genetic Engineering and Biotechnology Tehran Iran 

出 版 物:《Neural Regeneration Research》 (中国神经再生研究(英文版))

年 卷 期:2017年第12卷第7期

页      面:1186-1192页

核心收录:

学科分类:0710[理学-生物学] 1002[医学-临床医学] 1001[医学-基础医学(可授医学、理学学位)] 100204[医学-神经病学] 10[医学] 

主  题:nerve regeneration umbilical cord mesenchymal stem cells differentiation neuronal dopaminergicneurons dopamine substantia nigra ventral mesencephalon Parkinson's disease cell replacement therapy neural regeneration 

摘      要:Cell replacement therapy utilizing mesenchymal stem cells as its main resource holds great promise for ultimate treatment of human neurological disorders.Parkinson's disease(PD)is a common,chronic neurodegenerative disorder hallmarked by localized degeneration of a specific set of dopaminergic neurons within a midbrain sub-region.The specific cell type and confined location of degenerating neurons make cell replacement therapy ideal for PD treatment since it mainly requires replenishment of lost dopaminergic neurons with fresh and functional ones.Endogenous as well as exogenous cell sources have been identified as candidate targets for cell replacement therapy in PD.In this review,umbilical cord mesenchymal stem cells(UCMSCs)are discussed as they provide an inexpensive unlimited reservoir differentiable towards functional dopaminergic neurons that potentially lead to long-lasting behavioral recovery in PD patients.We also present mi RNAs-mediated neuronal differentiation of UCMSCs.The UCMSCs bear a number of outstanding characteristics including their non-tumorigenic,low-immunogenic properties that make them ideal for cell replacement therapy purposes.Nevertheless,more investigations as well as controlled clinical trials are required to thoroughly confirm the efficacy of UCMSCs for therapeutic medical-grade applications in PD.

读者评论 与其他读者分享你的观点

用户名:未登录
我的评分